OptiNose

OptiNose

OptiNose

OptiNose develops nasal drug delivery technologies and combined drug and devicetherapies.
Raised
$48.5M
Follow us
Alexa global traffic share
Latest funding
$48,500,000
Venture capital (Series C) - 2010
Team Size
10+
Employees
Location
Headquarters
PE HUB

VC-backed OptiNose debuts IPO

Stock markets Health